ClinicalTrialsFinder

Relapsed/Refractory Large B-Cell Lymphoma Clinical Trials in Tianjin, Tianjin Municipality

1 recruitingTianjin, Tianjin Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL

Relapsed/Refractory Large B-Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China89 enrolled1 locationNCT06489808